IL6R and cancer: For example, Ara and colleagues demonstrated that in neuroblastoma the bone marrow microenvironment is a source of IL-6 and sIL-6R, thereby allowing cancer cells to escape the cytotoxic effects of multiple chemotherapeutics (Ara et al., 2013).